Axonal targeting of the 5-HT 1B serotonin receptor relies on structure-specific constitutive activation

Traffic

Volumn 12, Issue 11, 2011, Pages 1501-1520

  Carrel, Damien ^a,b,c   Simon, Anne ^c   Emerit, Michel B ^a,b   Rivals, Isabelle ^d   Leterrier, Christophe ^b,c   Biard, Marc ^c   Hamon, Michel ^a,b   Darmon, Michèle ^a,b   Lenkei, Zsolt ^c  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

7 transmembrane receptor; Axon; Constitutive activity; p11; Polarized distribution; Targeting; Third intracellular loop

Indexed keywords

SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

ARTICLE; CHIMERA; CONTROLLED STUDY; DENDRITE; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; NERVE FIBER; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; AXONS; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOCYTOSIS; HELA CELLS; HIPPOCAMPUS; HUMANS; LLC-PK1 CELLS; MOLECULAR SEQUENCE DATA; NEURONS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RATS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE; TUMOR CELLS, CULTURED;

EID: 80053612907     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2011.01260.x     Document Type: Article

References (69)

1. Winckler B, Forscher P, Mellman I. A diffusion barrier maintains distribution of membrane proteins in polarized neurons. Nature 1999;397:698-701.
2. Nakada C, Ritchie K, Oba Y, Nakamura M, Hotta Y, Iino R, Kasai RS, Yamaguchi K, Fujiwara T, Kusumi A. Accumulation of anchored proteins forms membrane diffusion barriers during neuronal polarization. Nat Cell Biol 2003;5:626-632.
3. Burack MA, Silverman MA, Banker G. The role of selective transport in neuronal protein sorting. Neuron 2000;26:465-472.
4. Garrido JJ, Fernandes F, Giraud P, Mouret I, Pasqualini E, Fache MP, Jullien F, Dargent B. Identification of an axonal determinant in the C-terminus of the sodium channel Na(v)1.2. Embo J 2001;20: 5950-5961.
5. Sampo B, Kaech S, Kunz S, Banker G. Two distinct mechanisms target membrane proteins to the axonal surface. Neuron 2003;37:611-624.
6. Wisco D, Anderson ED, Chang MC, Norden C, Boiko T, Folsch H, Winckler B. Uncovering multiple axonal targeting pathways in hippocampal neurons. J Cell Biol 2003;162:1317-1328.
7. Yap CC, Nokes RL, Wisco D, Anderson E, Folsch H, Winckler B. Pathway selection to the axon depends on multiple targeting signals in NgCAM. J Cell Sci 2008;121:1514-1525.
8. Lasiecka ZM, Yap CC, Vakulenko M, Winckler B. Compartmentalizing the neuronal plasma membrane from axon initial segments to synapses. Int Rev Cell Mol Biol 2009;272:303-389.
9. Kobilka BK, Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007;28:397-406.
10. Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 2008;48:537-568.
11. Leterrier C, Laine J, Darmon M, Boudin H, Rossier J, Lenkei Z. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J Neurosci 2006;26: 3141-3153.
12. Holliday ND, Holst B, Rodionova EA, Schwartz TW, Cox HM. Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol 2007;21:3100-3112.
13. 1 cannabinoid receptor. J Biol Chem 2004; 279:36013-36021.
14. Marion S, Weiner DM, Caron MG. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 2004;279:2945-2954.
15. McCune DF, Edelmann SE, Olges JR, Post GR, Waldrop BA, Waugh DJ, Perez DM, Piascik MT. Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists. Mol Pharmacol 2000;57:659-666.
16. Pula G, Mundell SJ, Roberts PJ, Kelly E. Agonist-independent internalization of metabotropic glutamate receptor 1a is arrestin- and clathrin-dependent and is suppressed by receptor inverse agonists. J Neurochem 2004;89:1009-1020.
17. Tarasova NI, Stauber RH, Choi JK, Hudson EA, Czerwinski G, Miller JL, Pavlakis GN, Michejda CJ, Wank SA. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem 1997;272:14817-14824.
18. McDonald NA, Henstridge CM, Connolly CN, Irving AJ. An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor. Mol pharmacol 2007;71: 976-984.
19. 1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 1986;332:1-7.
20. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003;4: 1002-1012.
21. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
22. + channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience 1991;41:495-505.
23. Boschert U, Amara DA, Segu L, Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 1994;58:167-182.
24. 1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse 1995;19:18-28.
25. Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Vergé D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol 1996;365:289-305.
26. 1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 1999;88:899-915.
27. 1B serotonin receptors in adult rat brain. J Comp Neurol 2000;417:181-194.
28. 1B receptors expressed in epithelial LLC-PK1 cells. J Neurochem 1998;71:2294-2303.
29. 1B receptor in axonal-apical targeting. J Neurosci 2000;20:9111-9118.
30. Ascano M, Richmond A, Borden P, Kuruvilla R. Axonal targeting of Trk receptors via transcytosis regulates sensitivity to neurotrophin responses. J Neurosci 2009;29:11674-11685.
31. Bel C, Oguievetskaia K, Pitaval C, Goutebroze L, Faivre-Sarrailh C. Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis. J Cell Sci 2009;122:3403-3413.
32. Benmerah A, Poupon V, Cerf-Bensussan N, Dautry-Varsat A. Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J Biol Chem 2000;275:3288-3295.
33. Cao H, Garcia F, McNiven MA. Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell 1998;9:2595-2609.
34. 1B serotonin receptors in plasma membrane targeting. J Cell Sci 2006;119:4276-4284.
35. Subtil A, Gaidarov I, Kobylarz K, Lampson MA, Keen JH, McGraw TE. Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc Natl Acad Sci U S A 1999;96:6775-6780.
36. Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC. Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 2010;1801: 846-852.
37. Newman-Tancredi A, Audinot V, Moreira C, Verriele L, Millan MJ. Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry. Mol Pharmacol 2000;58:1042-1049.
38. 1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 1998;125:202-208.
39. Boess FG, Martin IL. Molecular biology of 5-HT receptors. Neuropharmacology 1994;33:275-317.
40. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999;1450:191-231.
41. 1B receptor function by p11 in depression-like states. Science 2006;311:77-80.
42. 1A serotonin receptor to neuronal dendrites is mediated by Yif1B. J Neurosci 2008;28: 8063-8073.
43. 1A receptors show constitutive activity. Mol Pharmacol 2007;71:638-643.
44. Newman-Tancredi A, Conte C, Chaput C, Verriele L, Millan MJ. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry. Neuropharmacology 1997;36:451-459.
45. Chakir K, Xiang Y, Yang D, Zhang SJ, Cheng H, Kobilka BK, Xiao RP. The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor. Mol Pharmacol 2003;64:1048-1058.
46. Schoneberg T, Schultz G, Gudermann T. Structural basis of G protein-coupled receptor function. Mol Cell Endocrinol 1999;151:181-193.
47. Weis WI, Kobilka BK. Structural insights into G-protein-coupled receptor activation. Curr Opin Struct Biol 2008;18:734-740.
48. Lee KB, Ptasienski JA, Pals-Rylaarsdam R, Gurevich VV, Hosey MM. Arrestin binding to the M(2) muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor. J Biol Chem 2000;275:9284-9289.
49. Peverelli E, Mantovani G, Calebiro D, Doni A, Bondioni S, Lania A, Beck-Peccoz P, Spada A. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation. Mol Endocrinol 2008;22: 676-688.
50. Granas C, Larhammar D. Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor. Eur J Pharmacol 1999;380:171-181.
51. Shi L, Javitch JA. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 2002;42:437-467.
52. Kenakin T. Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 2007;72:1393-1401.
53. Palanche T, Ilien B, Zoffmann S, Reck MP, Bucher B, Edelstein SJ, Galzi JL. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem 2001; 276:34853-34861.
54. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 2007;320: 1-13.
55. Peverelli E, Lania AG, Mantovani G, Beck-Peccoz P, Spada A. Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop. Endocrinology 2009;150:3169-3176.
56. Bockaert J, Fagni L, Dumuis A, Marin P. GPCR interacting proteins (GIP). Pharmacol Ther 2004;103:203-221.
57. Wu DF, Koch T, Liang YJ, Stumm R, Schulz S, Schroder H, Hollt V. Membrane glycoprotein M6a interacts with the micro-opioid receptor and facilitates receptor endocytosis and recycling. J Biol Chem 2007; 282:22239-22247.
58. Rescher U, Gerke V. Annexins-unique membrane binding proteins with diverse functions. J Cell Sci 2004;117:2631-2639.
59. Albert PR, Zhou QY, Van Tol HH, Bunzow JR, Civelli O. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem 1990;265: 5825-5832.
60. 1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mol Cell Neurosci 1992;3:578-587.
61. 1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons. Neuroscience 1996;74:297-302.
62. 1A receptors in the rat brain. Eur J Pharmacol 1997;337:297-308.
63. 35S]GTPgammaS binding in rat hippocampal membranes. Eur J Pharmacol 1998;343:303-312.
64. 1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 2000;12:2299-2310.
65. Miserey-Lenkei S, Parnot C, Bardin S, Corvol P, Clauser E. Constitutive internalization of constitutively active agiotensin II AT(1A) receptor mutants is blocked by inverse agonists. J Biol Chem 2002;277: 5891-5901.
66. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. 5th Edn. Upper Saddle River: Prentice Hall; 2002.
67. Kaufman L, Rousseeuw PJ. Finding Groups in Data: An Introduction to Cluster Analysis. Hoboken: John Wiley & Sons, Inc.; 1990.
68. Draper NR, Smith H. Applied Regression Analysis. 3rd Edn. New York: Wiley; 1998.
69. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003;31:3497-3500.